QPR / PGx
Withdrawal
OUD
AUD
Top 300
100

What is a behavioral clue that someone may have thoughts or intent to attempt suicide?

  • Any previous suicide attempts
  • Acquiring gun or stockpiling pills
  • Co-occurring depression, moodiness, hopelessness
  • Putting personal affairs in order
  • Giving away prized possessions
  • Sudden interest or disinterest in religion
  • Drug or alcohol abuse or relapse after a period of recovery
  • Increase anger
100

Which assessment tool is used to objectively measure alcohol withdrawal symptoms?

Clinical Institute Withdrawal Assessment for Alcohol (CIWA)

-Revised (CIWA-Ar)

100

Which setting is methadone legally dispensed through for the treatment of OUD?

Opioid treatment programs (OTPs)

100

A patient is interested in reducing their binge drinking. Which MAUD is least appropriate for them?

Disulfiram (Antabuse)

--

Better options: Naltrexone, topiramate, gabapentin

100

Which medication for OUD has a black box warning for risk of QT prolongation?

Methadone (Dolophine)

200

Which populations are at high risk for suicide?

  • Native American
  • Individuals bereaved by suicide
  • Medical conditions
  • LGBTQ
  • Armed force veterans
  • Midlife and older men (older than 75)
  • Mining construction
  • Mental health and SUD
  • Nonsuicidal self-injury
  • Justice and child welfare settings
  • Living in rural setting
200

A patient begins to have seizures on POD2. CT head rules out other causes. Nurses noted tremors the day prior. What substance is he most likely withdrawing from?

ALCOHOL

Initial symptoms begin within 24 hours - Tremor, anxiety, nausea, vomiting, irritability

Seizures may occur within 48 hours


Delirium tremens (DTs) typically occur 4-5 days after cessation - Autonomic instability, confusion, disorientation, and hallucinations


200

Describe two positive characteristics of buprenorphine/naloxone which set it apart from other MOUD treatment options?

SL formulations combined with naloxone to deter adulteration and misuse/diversion

a “ceiling effect” which reduces (but does not eliminate) the risk of abuse. Additionally, there is a lower risk of respiratory depression and overdoses on buprenorphine alone are uncommon

Patients may fill and pick up their prescription at a local pharmacy, usually for a week or so at a time initially, rather than presenting every day for their dose.

Can transition to different LAI options

Mild-moderate withdrawal

200

Which medication for AUD is best for a patient with severe hepatoxicity?

Acamprosate (Campral)

200

Which benzodiazepine is usually first line for alcohol withdrawal due to its long half-life?

Diazepam (Valium) --> active metabolites (temazepam, nordiazepam, oxazepam)


300

What is your goal of "persuasion" when preventing suicide?

For the person to agree to get help.

  • Listen to problem and give them your full attention
  • Private setting
  • Don’t be on your phone
  • Body language – eye contact, open body language, lean in
  • Remember suicide is not the problem, only the solution to the perceived insoluable problem
  • Don’t rush to judgment
  • Offer hope in any form
300

The onset and severity of opioid withdrawal symptoms generally depends on:

Type of opioid used (long-acting versus short-acting)

Short-acting (heroin, hydrocodone, oxycodone)

•Severe symptoms

•Onset: ~ 12 hours following missed dose

•Duration: ~4-7 days

Long-acting opioid (methadone)

•Milder symptoms

•Duration:  2 weeks or more

300

Please provide two (2) important counseling points for a patient who is newly starting on Naltrexone IM injection:

Indicated for OUD* and alcohol use disorder

MUST abstain from opioids for 7-10 days prior to administration to avoid precipitated withdrawal

Injectable suspension must ONLY be administered as a deep intramuscular gluteal injection

380mg every 28 days, alternating sides with each injection

S/sx of liver dysfunction or changes: Caution in hepatic insufficiency; not recommended in acute hepatitis or hepatic failure

Potential adverse effects: injection site reaction including nodule, swelling, pain, tenderness, itching, bruising, abscess, tissue necrosis

Opioid pain medications will be ineffective if needed in emergency or other acute situation

•Carry identification to alert medical personnel of use

•Will need to develop treatment plan for scheduled procedures which may require opioids

Increased sensitivity to opioids after treatment is discontinued, at the end of a dosing interval, or after a missed dose à elevated overdose risk

300

AK is a 52 year old male presenting to his PCP after a recent hospitalization for treatment of alcohol withdrawal. While admitted, he was diagnosed with Wernicke-Korsakoff syndrome and family confirm significant cognitive decline over the last few years. His sister recently moved in with him due to safety concerns and falls. 

PMH:HTN, GERD, and chronic pain. Renal and hepatic function are WNL. 

Current medications: atenolol 50mg daily, omeprazole 20mg BID, thiamine 100mg daily and hydrocodone/APAP 5mg/325mg BID PRN for pain.

The patient is interested in pursuing medication for AUD. What is the most appropriate pharmacologic treatment for this individual and why?

  • Acamprosate – first-line therapy, would recommend prior to pursuing non-FDA approved options with less evidence. Renal function WNL. No contraindications to acamprosate.  Not associated with CNS side effects which may increase his fall risk.


  • Alternate answer –  naltrexone ONLY if discontinue hydrocodone/APAP at least 7 days prior to initiation of naltrexone.
300

Which medications for alcohol use disorder (MAUD) require dose adjustment in renal impairment?

Topiramate (Topamax)

Gabapentin (Neurontin)

Acamprosate (Campral)

400

What is the effect of a CYP enzyme poor metabolizer (PM) phenotype on an active drug?

Reduced drug metabolism

Higher plasma concentration

Potential for increased adverse effects

400

What is the mechanism of action of lofexidine (Lucemyra)?

•α2- receptor agonist

•FDA-approved for opioid withdrawal symptoms

•NOT a treatment for opioid use disorder

•Usual dose: 0.54 mg (3 tablets) four times daily for 5-7 days

•“Lucemyra treatment may be continued for up to 14 days with dosing guided by symptoms.”

•Discontinue with gradual dose reduction over 2-4 days to avoid lofexidine discontinuation symptoms

•Adverse effects - Hypotension/bradycardia/orthostasis, Sedation, QTc prolongation, Dose adjustment needed for hepatic and renal impairment

400
A patient at your SUD clinic is interested in transitioning from daily Suboxone SL to a extended-release buprenorphine product. The provider would like you to educate the patient on differences between available products. What information do you provide?

Suboxone - subcutaneous

•Patients should be established on 8mg – 24 mg BUP daily

•300mg x 2, then transition to 100 or 300 mg every 28 days (must have at least 26 days between injections)

Brixadi - weekly or monthly SQ, dose depends on current oral dose and can be < 6mg

Both have a REMS program, so only administered by a healthcare professional 




400

JC is a 38 y/o who was admitted to your hospital overnight for alcohol withdrawal. He has a past medical history of AUD, HTN, and hypothyroidism. At the time of admission, his BAC was 233 and he had a UDS + cocaine. His renal and hepatic function are both within normal limits. 

You speak with him at the bedside to review home medications and notice he has not filled his HTN and thyroid medications in over 6 months and that he has several missed appointments documented in his chart. He says he tries to take medication daily but struggles with remembering doses. He estimates forgetting to take his maintenance medications about 2-3 times per week.

A few days later, you receive a call from his medical team saying JC is interested in starting medication assisted therapy for alcohol use disorder. What is the most appropriate pharmacologic treatment for this patient and why?

Naltrexone - can start with oral naltrexone to assess tolerability and transition to once-monthly IM Vivitrol injection due to history of poor adherence. 


400

A 26 year old presents to the ED with a BAC of 265 and becomes acutely agitated requiring medication management. What do you recommend?  

If able to take PO --> olanzapine, haloperidol, risperidone


IM SGA --> ziprasidone or olanzapine

IM FGA --> haloperidol

Avoid benzo during acute intoxication with CNS depressant



500

What are two possible benefits of pharmacogenomic testing? 

One-time testing

Less trial and error with medications.

Fewer adverse drug reactions

Improved adherence

Improved satisfaction/ trust in provider

500

Which medication has been shown to effectively treat mild-moderate alcohol withdrawal syndrome with lower risk of CNS sedation compared to benzodiazepines?

Gabapentin (Neurontin)

500

What do you do in the case of a suspected opioid overdose?

  • Check for slowed breathing or unresponsiveness. 
  • Check for a pulse --> CPR
  • Administer IN Narcan - Lay the person on their back and tilt the head up. Insert device into either nostril and press plunger firmly. 1 nasal spray device contains 1 dose.
  • Call 911 immediately after giving the first dose, if haven't done so already. 
  • Continue to administer doses every 2-3 minutes and wait with the person until help arrives.
  • Safe to keep giving doses as needed.
  • Delayed onset of effect with IN vs IV
500

What are important counseling points for a patient starting disulfiram?

Irreversible inhibitor of aldehyde dehydrogenase - Duration of effect may last up to 2 weeks while body generates new enzyme

Avoid all forms of alcohol, including topical products

Not appropriate therapy for patients who are unable to understand consequences of alcohol use and consent to treatment

Adverse effects: drowsiness, metallic taste, hepatitis

500

A patient takes Tegretol for seizures. What impact would this have on a patient taking buprenorphine?

CYP3A4 inducer --> may decrease serum concentrations of buprenorphine


Also interacts with methadone!!

M
e
n
u